Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26124 | 217 | 34.9 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CASP10 | Author keyword | 4 | 56% | 2% | 5 |
| 2 | CASP8 | Author keyword | 4 | 30% | 5% | 10 |
| 3 | CASPASE 10 | Author keyword | 3 | 26% | 4% | 9 |
| 4 | FUDAN TAIZHOU HLTH SCI | Address | 2 | 67% | 1% | 2 |
| 5 | CASP 9 | Author keyword | 1 | 50% | 1% | 2 |
| 6 | CASP8 652 6N DEL | Author keyword | 1 | 100% | 1% | 2 |
| 7 | CASPASE8 | Author keyword | 1 | 100% | 1% | 2 |
| 8 | ASTRAGALUS MEMBRANCEUS | Author keyword | 1 | 50% | 0% | 1 |
| 9 | CANC DHHS | Address | 1 | 50% | 0% | 1 |
| 10 | CASPASE GENE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CASP10 | 4 | 56% | 2% | 5 | Search CASP10 | Search CASP10 |
| 2 | CASP8 | 4 | 30% | 5% | 10 | Search CASP8 | Search CASP8 |
| 3 | CASPASE 10 | 3 | 26% | 4% | 9 | Search CASPASE+10 | Search CASPASE+10 |
| 4 | CASP 9 | 1 | 50% | 1% | 2 | Search CASP+9 | Search CASP+9 |
| 5 | CASP8 652 6N DEL | 1 | 100% | 1% | 2 | Search CASP8+652+6N+DEL | Search CASP8+652+6N+DEL |
| 6 | CASPASE8 | 1 | 100% | 1% | 2 | Search CASPASE8 | Search CASPASE8 |
| 7 | ASTRAGALUS MEMBRANCEUS | 1 | 50% | 0% | 1 | Search ASTRAGALUS+MEMBRANCEUS | Search ASTRAGALUS+MEMBRANCEUS |
| 8 | CASPASE GENE | 1 | 50% | 0% | 1 | Search CASPASE+GENE | Search CASPASE+GENE |
| 9 | CASPASE7 | 1 | 50% | 0% | 1 | Search CASPASE7 | Search CASPASE7 |
| 10 | CHICKEN BILE | 1 | 50% | 0% | 1 | Search CHICKEN+BILE | Search CHICKEN+BILE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CASPASE 8 GENE | 6 | 39% | 6% | 12 |
| 2 | D302H VARIANT | 6 | 100% | 2% | 4 |
| 3 | CASP8 PROMOTER | 3 | 57% | 2% | 4 |
| 4 | CASP10 GENE | 3 | 100% | 1% | 3 |
| 5 | INACTIVATING MUTATIONS | 3 | 12% | 11% | 24 |
| 6 | DEL PROMOTER POLYMORPHISM | 3 | 60% | 1% | 3 |
| 7 | CASP8 GENE | 2 | 44% | 2% | 4 |
| 8 | PATHWAY CONFER SUSCEPTIBILITY | 2 | 40% | 2% | 4 |
| 9 | DEATH PATHWAY GENES | 2 | 19% | 3% | 7 |
| 10 | CASPASE GENES | 1 | 100% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Caspases and cancer | 2011 | 65 | 77 | 18% |
| CASP8-652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis | 2014 | 1 | 15 | 60% |
| Personalized assisted reproductive technology | 2013 | 0 | 1 | 100% |
| Caspase-8 in cancer biology and therapy | 2009 | 80 | 71 | 20% |
| Apoptosis and cancer: mutations within caspase genes | 2009 | 197 | 196 | 8% |
| Old, new and emerging functions of caspases | 2015 | 6 | 192 | 10% |
| HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk | 2013 | 1 | 31 | 45% |
| CASP-8-652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis | 2012 | 1 | 34 | 47% |
| The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer | 2012 | 16 | 52 | 13% |
| A literature-based systematic HuGE review and meta-analysis show that CASP gene family polymorphisms are associated with risk of lung cancer | 2013 | 0 | 29 | 34% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FUDAN TAIZHOU HLTH SCI | 2 | 67% | 0.9% | 2 |
| 2 | CANC DHHS | 1 | 50% | 0.5% | 1 |
| 3 | CCG OSTEOSARCOMA | 1 | 50% | 0.5% | 1 |
| 4 | EUROPEEN RECH POLYARTHRITE RHUMATOIDE | 1 | 50% | 0.5% | 1 |
| 5 | GEN SURG WARD 2 | 1 | 50% | 0.5% | 1 |
| 6 | MINIST EDUCSTATE GENET ENGN | 1 | 50% | 0.5% | 1 |
| 7 | MUNICH GERMAN ENVIRONM HLTH | 1 | 50% | 0.5% | 1 |
| 8 | NIHDHHSMSC 7240 | 1 | 50% | 0.5% | 1 |
| 9 | U1365 | 1 | 50% | 0.5% | 1 |
| 10 | CANC EPIDEMIOL GENETCORE GENOTYPING IL | 0 | 33% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000191165 | APAF 1//CASPASE 2//RAIDD |
| 2 | 0.0000149274 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
| 3 | 0.0000109604 | CHEK2//PALB2//SERV CIRUGIA GEN ESPECIALIDADES |
| 4 | 0.0000102156 | TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND |
| 5 | 0.0000087485 | PROSTATE STEM CELL ANTIGEN//PROSTATE STEM CELL ANTIGEN PSCA//PSCA |
| 6 | 0.0000082136 | FAS//FAS LIGAND//AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME |
| 7 | 0.0000067669 | BCL2L12//BCL2 FAMILY//G P ANICOLAOU ONCOL |
| 8 | 0.0000047313 | EGF POLYMORPHISM//GEFITINIB THERAPY//INTRON 1 POLYMORPHISM |
| 9 | 0.0000045682 | TNFAIP8//TIPE2//TNFAIP8L2 TIPE2 |
| 10 | 0.0000044314 | SURVIVIN//YM155//SURVIVIN EXPRESSION |